Section Arrow
PULM.NASDAQ
- Pulmatrix
Quotes are at least 15-min delayed:2024/05/16 10:43 EDT
Last
 1.8401
+0.0101 (+0.55%)
Day High 
1.88 
Prev. Close
1.83 
1-M High
2.19 
Volume 
4.57K 
Bid
1.84
Ask
1.88
Day Low
1.83 
Open
1.8301 
1-M Low
1.73 
Market Cap 
6.68M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.87 
20-SMA 1.92 
50-SMA 1.87 
52-W High 2.9103 
52-W Low 1.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.42/-4.95
Enterprise Value
15.01M
Balance Sheet
Book Value Per Share
5.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.30M
Operating Revenue Per Share
1.90
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
JAGXJaguar Health0.268+0.0129+5.06%-- 
SCPXScorpius Holdings0.0998+0.0221+28.44%-- 
DNAGinkgo Bioworks Holdings0.8177-0.0214-2.55%-- 
NVAXNovavax12.9--0.000%-- 
NBYNovaBay Pharmaceuticals0.10305-0.00145-1.39%-- 
Quotes are at least 15-min delayed:2024/05/16 10:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmetmedical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.